Pharmacogenomics of cytochrome P450 and other enzymes involved in biotransformation of xenobiotics
- 1 January 2000
- journal article
- research article
- Published by Wiley in Drug Development Research
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Multisubstrate flavin-containing monooxygenases: applications of mechanism to specificityPublished by Elsevier ,2000
- Conjugation of Highly Reactive Aflatoxin B1 exo-8,9-Epoxide Catalyzed by Rat and Human Glutathione Transferases: Estimation of Kinetic ParametersBiochemistry, 1997
- P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclaturePharmacogenetics, 1996
- Genetic susceptibility and the common cancersBiomarkers, 1996
- Inhibition of Terfenadine MetabolismClinical Pharmacokinetics, 1994
- Pharmacogenetic Phenotyping and GenotypingClinical Pharmacokinetics, 1994
- Inhibition by pentachlorophenol of the initiating and promoting activities of 1′-hydroxysafrole for the formation of enzyme-altered foci and tumors in rat liverCarcinogenesis: Integrative Cancer Research, 1987
- Heterogeneity and new molecular forms of human liver alcohol dehydrogenaseBiochemical and Biophysical Research Communications, 1979
- ANTI-EPILEPTIC DRUGS AND FAILURE OF ORAL CONTRACEPTIVESThe Lancet, 1974
- Ueber Verwandlung der Benzoësäure in HippursäureEuropean Journal of Organic Chemistry, 1842